Evaluation of protection conferred by several acellular pertussis vaccines in an intranasal model of B. pertussis infection.
Hauser
P
P
SmithKline Beecham Biologicals, 89 rue de l'Institut, Rixensart, 1330, Belgium.
Simoen
E
E
Capiau
C
C
Comberbach
M
M
Desmons
P
P
Veenstra
S
S
Slaoui
M
M
D000281:Administration, Intranasal; D016667:Bacterial Capsules; D018073:Haemophilus Vaccines; D006801:Humans; D007223:Infant; D010567:Pertussis Vaccine / Q000008:administration & dosage*; D011054:Poliovirus Vaccine, Inactivated; D011135:Polysaccharides, Bacterial; D017778:Vaccines, Combined
D018073:Haemophilus Vaccines; C044237:Haemophilus influenzae type b polysaccharide vaccine; D010567:Pertussis Vaccine; D011054:Poliovirus Vaccine, Inactivated; D011135:Polysaccharides, Bacterial; D017778:Vaccines, Combined